Key facts
- This page summarizes Thomas G. Frinzi's Form 4 filing for STAAR SURGICAL CO (STAA).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 14 Mar 2024, 17:20.
Thomas G. Frinzi - 12 Mar 2024 Form 4 Insider Report for STAAR SURGICAL CO (STAA)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- STAA
- Reported as of
- 12 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Mar 2024, 17:20:56 UTC
- Prior SEC filing
- 03 Jan 2024
- Next SEC filing
- 06 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nathaniel Sisitsky as attorney-in-fact for Thomas G. Frinzi
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas G. Frinzi filed Form 4 for STAAR SURGICAL CO (STAA) on 14 Mar 2024.
Change
- Previous filing in this sequence was filed on 03 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
STAA
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +74,389
- Change %
- Price
- $0.000000
- Shares after
- 74,389
- Date
- 12 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 74,389
- Exercise price
- $0.000000
- Footnotes
- F1, F2
STAA
transaction
Derivative
Common Stock Options
Award
- Transaction value
- $0
- Shares
- +66,627
- Change %
- Price
- $0.000000
- Shares after
- 66,627
- Date
- 12 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 66,627
- Exercise price
- $37.64
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
Footnote F2
RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (24,796 shares) on March 12, 2025, 1/3 (24,796 shares) on March 12, 2026, and 1/3 (24,797 shares) on March 12, 2027.
Footnote F3
Stock options granted to the Reporting Person on March 12, 2024. Options will vest and become exercisable as to 1/3 (22,209 shares) on March 12, 2025, with the remaining 2/3 (44,418 shares) vesting and becoming exercisable monthly over the following 24 months in equal amounts on a monthly basis. In the event such amount does not evenly divide into 24 months, the remaining balance of options will vest and become exercisable on March 12, 2027.